Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation
Yulin Liao(Center for Life Sciences), Masatsugu Hori(Osaka National Hospital), Hiroshi Asanuma(Meiji University of Integrative Medicine), Hisakazu Ogita(Shiga University of Medical Science), Koichi Node(Saga University), Masanori Asakura(National Cerebral and Cardiovascular Center), Masafumi Kitakaze(Hanwa Memorial Hospital), Shoji Sanada(Kobe University Hospital), Seiji Takashima(The University of Osaka), Jiyoon Kim(The University of Osaka), Fuminobu Ishikura(National Cerebral and Cardiovascular Center), Tsunehiko Kuzuya(The University of Osaka), Shintaro Beppu(Osaka Hospital)
American Journal of Physiology-Heart and Circulatory Physiology
May 1, 2002
Cited by 136
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
|Journal of Clinical Investigation|2007|1k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Metformin Prevents Progression of Heart Failure in Dogs
|Circulation|2009|288
Physiological Diagnostic Criteria for Vascular Failure
|Hypertension|2018|282